AB

Anwesha Basu Mukherjee

Active Director Director DIN 09841674
DIN 09841674 First appointment Dec 2022 Primary industry Healthcare
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Anwesha Basu Mukherjee

Data last updated:

Anwesha Basu Mukherjee is a Director at Hospimates Mediserv Private Limited (since 2022). The company operates in Healthcare.

DIN 09841674
Primary Designation Director
Industry Healthcare
First Appointment 29 Dec 2022
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hospimates Mediserv Private Limited U85300WB2022PTC259314
Director29 Dec 20222022Active

Board colleagues of Anwesha Basu Mukherjee

NameDINCompanyDesignation
Indranil Mukherjee09841673Hospimates Mediserv Private LimitedDirector

Directorship timeline

Open interactive timeline →
Hospimates Mediserv Private Limited
Premium access

Shareholding and investment profile for Anwesha Basu Mukherjee

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Anwesha Basu Mukherjee

Anwesha Basu Mukherjee currently holds 1 directorship: Hospimates Mediserv Private Limited (Director, since 29 Dec 2022).

Anwesha Basu Mukherjee was first appointed on 29 Dec 2022 as Director at Hospimates Mediserv Private Limited.

The current boards of Anwesha Basu Mukherjee's companies include Indranil Mukherjee (Hospimates Mediserv Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available